Browsing Tag
Wellnex Life Limited
3 posts
Wellnex Life completes A$19.8m Pain Away sale and becomes a very different healthcare business
Wellnex Life Limited has completed the Pain Away divestment for A$19.8 million upfront and up to A$1.5 million more, trading a major revenue contributor for debt reduction, liquidity and a smaller capital-light healthcare model.
Wellnex Life (ASX: WNX) wins vote for A$21.3m Pain Away sale and debt exit
Wellnex Life shareholders have approved the sale of Pain Away to Mentholatum Australasia for up to A$21.3 million, clearing a key condition for a transaction expected to eliminate approximately A$10.2 million of borrowings but also remove more than half of FY26 group revenue.
Wellnex Life targets UK market with WRAP Retail Offer and AIM listing
Wellnex Life launches a ÂŁ0.3 million WRAP Retail Offer ahead of its AIM listing. Learn how this move could impact its stock performance and investor outlook.